ESAO - IFAO Program, as of 03-08-2017 · 2017-08-04 · ESAO - IFAO Program, as of 03-08-2017 Tuesday, 05.09.201712:30- 18:00Hall: 7 PC1PreCongress Meeting: yESAO (I) 12:30 "The Grand

ESAO - IFAO Program, as of 03-08-2017

Tuesday, 05.09.2017 12:30 - 18:00 Hall: 7

PC1 PreCongress Meeting: yESAO (I)

12:30 "The Grand Waltz of Artificial Organs"Please find detailed program at the end of this document

20:00 yESAO Come Together

Wednesday, 06.09.2017 09:00 - 12:00 Hall: 7

PC2 PreCongress Meeting: yESAO (II)

Please find detailed program at the end of this document

06.09.2017,Wednesday 09:00 12:00 23, 27-30Hall:-

PC3

T. Schlöglhofer Vienna, ATD. Christensen Pine Grove, US

PreCongress Meeting: ICCAC/ESAO MCS Proficiency Course

Chairs :

Separate ticket required. Please, find the detailed program at the end of the document

Wednesday, 06.09.2017 12:00 - 13:00 Hall:

LU Lunch

Wednesday, 06.09.2017 13:00 - 15:30 Hall: 7

PC4 PreCongress Meeting: yESAO (III)

Please find detailed program at the end of this document

06.09.2017,Wednesday 13:00 15:30 23, 27-30Hall:-

PC5

T. Schlöglhofer Vienna, ATD. Christensen Pine Grove, US

PreCongress Meeting: ICCAC/ESAO MCS Proficiency Course

Chairs :

Separate ticket required. Please, find the detailed program at the end of the document

06.09.2017,Wednesday 16:00 18:00 1Hall:-

OC

H. Klinkmann Rostock, DEU. Losert Vienna, AT

Opening Ceremony

Chairs :

Presidential Address

H. Schima; Vienna, AT

Welcome Address of the IFAO President

B. Stegmayr; Umea, SE

Welcome Address of the ESAO President

T. Groth; Halle, DE

Welcome Address of the General Manager of Ludwig Boltzmann Society

C. Lingner; Vienna, AT

Welcome Address of the President of the Medical University Vienna

M. Müller; Vienna, AT

ESAO Wichtig Research Award and ESAO PhD Award

Bioinspired Engineering: From Human Organs-on-Chips to Dialysis-Like Therapeutic Devices

OL

D. Ingber; Boston, US

Musical Performance by G. Petkov (Opera Singer and 1st recipient of the Heartware HVAD)

accompanied on the piano by P. Stoiano

07.09.2017,Thursday 08:30 09:30 2Hall:-

A11

J. Long Oklahoma City, USG. Laufer Vienna, AT

Symposium: Challenges in Development and Application of VADs (sponsored by Medtronic Inc.)

Chairs :

08:30 Intelligent Monitoring of Patients and their VADs

IL

F. Moscato; Vienna, AT

08:45 Challenges of minimal invasive implantsIL

D. Zimpfer; Vienna, AT

09:00 Current progress of VAD-implantation in Japan

IL

T. Nishimura; Tokyo, JP

09:15 Analytic reports from J-MACS: Focusing on the differences from the results of other VAD registries

IL

M. Ono; Tokyo, JP

07.09.2017,Thursday 08:30 09:30 4Hall:-

B11

P. Ladyzinski Warsaw, PLM. Fischer Krems, AT

Liver Failure

Chairs :

08:30 MARS efficiency according to treatment modalities: Experience in patients affected by acute-on-chronic liver failure (ACLF) and comparison with data reported in the literature

O

R. Marangoni; Como, IT

1

08:42 Molecular Adsorbent Recirculating System (MARS) in acute liver injury and graft dysfunction: Results from a case control study

O

H. Gerth; Muenster, DE

2

08:54 Effects of normothermic liver perfusion after 1 hour of warm ischemia

O

I. Fernandez-Lopez; Madrid, ES

3

09:06 Liver functionality model during normothermic perfusion

O

A. Rivera; Madrid, ES

4

07.09.2017,Thursday 08:30 09:30 3Hall:-

C11

R. Gruber Vienna, ATS. Iwanaga Toyama, JP

Biomaterials I: Hard Tissue Replacement

Chairs :

08:30 Structure and properties of carbon fiber-reinforced hydroxyapatite composite matrix

O

N. Arkharova; Moscow, RU

5

08:40 Supramolecular gelatin nano-composites with enhanced sol-gel transition temperature

O

M. Mohseni Moghaddam; Tehran, IR

6

08:50 Experimental investigation and numerical analysis of the PMMA-based biocompatible vertebral cement flow

O

D. Obidowski; Lodz, PL

7

09:00 Transformation of Hydrogel Scaffolds using Ultrashort Laser Pulses for Tissue Engineering

O

M. Savelyev; Zelenograd, RU

8

09:10 Osteo-balls with Organic-Inorganic Chimeric Hydrogel Microbeads for Rapid Bone Formation

O

S. Iwanaga; Toyama, JP

9

09:20 Bone ingrowth in macro porous tricalcium phosphate implants produced by lithography-based ceramic manufacturing (LCM)

O

D. Bomze; Vienna, AT

10

07.09.2017,Thursday 08:30 09:30 9Hall:-

D11

W. Mayr Vienna, ATM. Bijak Vienna, AT

Symposium: Limb Prostheses

Chairs :

08:30 Technical Design Considerations for Restauration of Prostheses based Movements

IL

W. Mayr; Vienna, AT

08:54 Development of a modular bionic prototype arm prosthesis

O

C. Kast; Vienna, AT

11

09:06 A Preliminary Test of Online Learning FES Control by Feedback Error Learning Using Fuzzy Controller in Controlling Knee Extension Movement

O

T. Watanabe; Sendai, JP

12

09:18 Development process of prosthetic device for upper limb

O

O. Canciglieri Junior; Curitiba, BR

13

07.09.2017,Thursday 09:30 10:30 1Hall:-

PL I

E. Wolner Vienna, AT

Plenary Session I

Chairs :

09:30 The future of Mechanical Cardiac Support

PL

J. Long; Oklahoma City, US

1

10:00 Development of Complex Air-way Tissue Models and their Biomedical Applications

PL

H. Walles; Würzburg, DE

2

07.09.2017,Thursday 11:00 12:30 2Hall:-

A12

E. Tatsumi Osaka, JPL. Fresiello Leuven, BE

Heart & Pump: Modelling and Control

Chairs :

11:00 Venous physiology and cavopulmonary support in Fontan patients

O

M. Granegger; Zurich, CH

14

11:15 Exercise physiology with a VAD: study of left ventricular energetics with a computational model

O

L. Fresiello; Leuven, BE

15

11:30 In-Vitro Evaluation of Starling-like Control Based on Estimated Left Ventricular Stroke Work

O

E. Wu; Brisbane, AU

16

11:45 Stroke volume estimation and extreme membrane positions detection in pulsatile ventricular assist device.

O

A. Siewnicka; Warsaw, PL

17

12:00 Cardiac contractility index derived from pump flow during external rotary blood pump support: an in vitro study

O

P. Naiyanetr; Nakorn Pathom, TH

18

12:15 ECG-synchronized rotational speed change system has preventive effect on right heart failure during continuous-flow left ventricular assist device support.

O

D. Akiyama; Suita, Osaka, JP

19

07.09.2017,Thursday 11:00 12:30 4Hall:-

B12

C. Legallais Compiegne, FRL. Kramer (tbc) Vienna, AT

Materials in Aphereses and Dialysis

Chairs :

11:00 Blood-Biomaterial Interactions in Extracorporeal Circulation.

O

A. Campbell Ritchie; Nottingham, GB

20

11:12 Mixed matrix membranes for outside-in dialysis

O

O. ter Beek; Enschede, NL

21

11:24 Mixed matrix membranes for the removal of endotoxins during hemodialysis

O

I. Geremia; Enschede, NL

22

11:36 Integrally skinned asymmetric cellulose acetate-silica membranes for extracorporeal blood ultrafiltration.

O

M. Faria; Lisbon, PT

23

11:48 Interpreting pore size values in membranes for renal replacement therapy

O

A. Boschetti-de-Fierro; Hechingen, DE

24

12:00 Biocompatible comparison in polysulfone membranes between polyvinylpyrrolidone and hydrophilic polymer coating for hemodialysis

O

K. Togo; Tokyo, JP

25

12:12 Assessment of blood trauma due to hematocrit variations in dialyzers

O

F. Mouzakis; Aachen, DE

26

07.09.2017,Thursday 11:00 12:30 3Hall:-

C12

N. Neves Minho, PTT. Groth Halle, DE

Symposium: Tissue Regeneration (in cooperation withTERMIS)

Chairs :

11:00 Soft-biomimetic environments to support cell organization and function

IL

J. Mano; Aveiro, PT

11:20 Biomimetic Materials for Cartilage Engineering

IL

M. Zenobi-Wong; Zuerich, CH

11:40 Engineering hydrogels to promote cell differentiation in soft tissue regeneration

IL

G. Gallego-Ferrer; Valencia, ES

12:00 Combining surface functionalized scaffolds with stem cells for advanced therapies

IL

N. Neves; Minho, PT

12:20 Discussion

07.09.2017,Thursday 11:00 12:30 9Hall:-

D12

J. Vienken Usingen, DEU. Baurmeister Wupperthal, DE

Symposium: New Aspects of Albumin (Albunet)

Chairs :

11:00 The European ALBUNET network: Mission and Visions

O

J. Vienken; Usingen, DE

27

11:10 Analysis of albumin function by investigating conformational mobility

O

K. Schnurr; Berlin, DE

28

11:30 Non-invasive monitoring of bilirubin decrease in extracorporeal liver support patients

O

M. Preussiger; Wuppertal, DE

29

11:50 Extracorporeal liver support: Approaching the patient with liver failure

O

B. Tyczynski; Essen, DE

30

12:10 OPAL vs MARS:A case control study of two extracorporeal albumin dialysis techniques

O

C. Wilms; Münster, DE

31

07.09.2017,Thursday 12:30 14:00 1Hall:-

LS I

A. Menon Berlin, DE

Lunch with Corporate Member Symposium: Optimizing Hemocompatibility - Opportunity and Challenge for Developers

Chairs :

Peristaltik vs. Membran Pumps in Purification Techniques- What's New?

O. Favre; Geneva, CH

Optimizing hemocompatibility in VADs

A. Wisniewski; Berlin, DE

Access to clean water – core for dialysis

G. Grundström; Deerfield, US

07.09.2017,Thursday 14:00 15:30 2Hall:-

A13

T. Schlöglhofer Vienna, ATP. Combs Oak Lawn, US

Symposium: ICCAC-ESAO International VAD Coordinators

Chairs :

14:00 Blood pressure management in VAD patients: same limitations, new ideas?

IL

D. Robson; Sydney, AU

14:12 Why Did you Implant That Patient: The Vad Coordinator as Link between ICU and VAD Team

IL

H. Moody; Louisville, US

14:24 Vad Simulation for Staff Education- Practice Makes Perfect

IL

T. Elliott; Washington, US

14:36 Driveline Infections: Accept the challenge

IL

P. Combs; Oak Lawn, US

14:48 Do LVAD patients need a specific diet to control weight ?

O

K. Vandersmissen; Leuven, BE

32

15:00 Dying on a device: Challenges in end-of-life care of VAD patients

IL

D. Roefe; Bad Oeynhausen, DE

15:12 Caring for the pediatric VAD patient - they aren't just small adults

IL

J. Lantz; Dallas, US

07.09.2017,Thursday 14:00 15:30 4Hall:-

B13

V. Weber Krems, ATV. Witt Vienna, AT

Symposium: Citrate Anticoagulation

Chairs :

14:00 Regional citrate anticoagulation in continuous renal replacement therapy

IL

T. Slowinski; Berlin, DE

14:20 Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients

IL

L. Kramer; Vienna, AT

14:40 Citrate, use and proof of the use in pediatric apheresis

IL

V. Witt; Vienna, AT

15:00 Influence of Citrate Concentration on Platelet Activation During Lipid Apheresis

O

R. Weiss; Krems, AT

33

15:15 Citrate Clearance of Current Dialysers: An In Vitro Study

O

J. Hartmann; Krems, AT

34

07.09.2017,Thursday 14:00 15:30 3Hall:-

C13

H. Bergmeister Vienna, ATT. Walles (tbc) Magdeburg, DE

Tissue Engineering & Regenerative Medicine I

Chairs :

14:00 Preliminary clinical results of the bioartificial TraVaSc Implant for airway reconstruction

IL

T. Walles; Magdeburg, DE

14:20 3D-bioprinted capillary-like networks as versatile organ-on-a-chip platform

O

A. Blaeser; Aachen, DE

35

14:32 Tissue-engineered heart valve can change histological character after implantation

O

Y. Takewa; Osaka, JP

36

14:44 Reconstructing the blood vasculature within decellularized liver for generating a functional humanized organ

O

K. Hussein; Chuncheon, KR

37

14:56 Effect of porosity in freeze-dried decellularized porcine pulmonary heart valves on proteins and biomechanical properties

O

A. Vásquez-Rivera; Hannover, DE

38

15:08 Mid-term outcome of Cardiac Regenerative Therapy with Autologous Myoblast Cell Sheet Transplantation for Ischemic Cardiomyopathy

O

K. Domae; Suita, Osaka, JP

39

15:20 Discussion

07.09.2017,Thursday 14:00 15:30 9Hall:-

D13

B. Podesser Vienna, ATK. Toda Osaka, JP

Symposium: Cardiac Valves

Chairs :

14:00 Current topics and future perspectives of surgery for valve disease in Japan

IL

K. Toda; Osaka, JP

14:30 In vitro calcification and mechanical loading on heart valves: development of new and improved model of in vivo processes

O

D. Mavrilas; Patras, GR

40

14:40 Functional Mitral Regurgitation Model in an Ex-Vivo Platform.

O

M. Jaworek; Milano, IT

41

14:50 In-vivo evaluation of ConVes a novel device for a sutureless aortic graft anastomosis

O

S. Dual; Zürich, CH

42

15:00 Development of an innovative design for a large-size percutaneous pulmonary valve prosthesis

O

A. Gruenwald; Aachen, DE

43

15:10 Discussion

07.09.2017,Thursday 15:30 16:30 HallwayHall:-

PS1

B. Biocina Zagreb, HRB. Steinlechner (tbc Vienna, AT

Cardiac Assist Devices in Clinical Application I

Chairs :

Destination Therapy LVAD and Cancer: A case against Darwin’s Survival of the Fittest

P

L. Samuels; Philadelphia, US

1

Predictor for weaning from extracorporeal membrane oxygenation in infants with heart failure

P

T. Goto; HIrosaki, JP

2

The experience on technical supervision of patients supported by HVAD system

P

R. Kustosz; Zabrze, PL

3

Blood pressure control in heart failure patients supported by a centrifugal left ventricular assist device

P

N. Reiss; Bad Rothenfelde, DE

4

Effects of Ventricular Assist Device on cardiac troponin T isoform expression in pediatric patients with heart failure.

P

R. Ragusa; Pisa, IT

5

Outcomes of heart transplantation following support by MicroMed® DeBakey VAD® versus Heartware® HVAD® – A single center study.

P

P. Angleitner; Vienna, AT

6

Minimally invasive biventricular support with percutaneous extracorporeal membrane oxygenation and left ventricular assist system through mini-thoracotomy

P

K. Domae; Suita City, Osaka, JP

7

Mapping and ablation during mechanical circulatory support (BerlinHeart) in a child with diagnosed tachycardia-induced cardiomyopathy. Is this the way to wean?

P

J. Śliwka; Zabrze, PL

8


PS2

P. Bonde New Haven, USD. Wiedemann Vienna, AT

Cardiac Assist Devices in Clinical Application II

Chairs :

Cardiac rehabilitation of left ventricular assist device patients requiring renal replacement therapy - a major challenge

P


9

The Experience of using ECMO on an infant after Modified Nikaidoh Procedure.

P

Q. Wu; Beijing, CN

10

The usefulness of peripheral ECMO as a bridge to implantable LVAD in progressive decline heat failure patients

P

H. Hata; Suita, Osaka, JP

11

Clinical Course, Functional Capacity and Discontinuation of RVAD after Planned and Unplanned Biventricular Support System Implantation

P


12

Short and long term left and right ventricular mechanics after LVAD implantation in pediatric patients: a 2D and 2Dspeckle tracking echocardiographic study

P

R. Iacobelli; Rome, IT

13

Do adults with a durable continuous-flow left ventricular assist device (LVAD) require an assigned caregiver on discharge?

P

D. Robson; Sydney, AU

14

International VAD Coordinator Practices: Clinical Utility and Application of HeartWare HVAD System Waveforms and Logfiles

P

T. Schlöglhofer; Vienna, AT

15

Development of a Suction Detection Algorithm from Patient Pump Data.

P

M. Maw; Vienna, AT

16


PS3

J. Woodard Sydney, AUS. Sonntag Aachen, DE

Cardiac Assist Devices: Blood Trauma and Various Topics

Chairs :

The Evaluation of Hemolysis in a Ventricular Assist Device-Preliminary study

P

Y. Zhang; Beijing, CN

17

Blood damage by handling: The crux of the matter

P

L. Wiegmann; Zurich, CH

18

Influence of the thrombus formation on the heat generation in the Sputnik RBP: In vitro studies

P

A. Porfiryev; Moscow, RU

19

Regurgitant flow in mechanical heart valves: fluid stresses and spatial correlation

P

M. Grigioni; Rome, IT

20

Oxidative stress increases susceptibility of red blood cells to shear-mediated damage

P

A. McNamee; Gold Coast, AU

21

Haemodilution Increases the Fragility of Red Blood Cells in Response to Mechanical Stress

P

C. Robinson; Swansea, GB

22

Erythrocyte tolerance to supra-physiological shear stress with exposure times reflective of clinical blood pumps

P

J. Horobin; Gold Coast, AU

23

Inductive energy transfer for personalized artificial organs

P

A. Danilov; Moscow, RU

24

Efficiency Measurement of Air-Core Transcutaneous Energy Transmission Systems for Ventricular Assist Devices Considering Common-Mode Currents for a Transformer Immersed in a NaCl Solution at a Transmission Frequency of 500 kHz

P

T. Kaga; Katsushika, JP

25

Transcutaneous energy transmission by capacitive coupling

P

E. Drigo; Sao Paulo, BR

26

Transcutaneous Energy Transmission using Capacitive Coupling for Cardiac Pacemaker: Calculation of AC-AC Energy Transmission Efficiency

P

S. Kometani; Katsushika, JP

27

Experimental and Numerical Analysis of Dye Washout in Ventricular Assist Devices

P

A. Molteni; Swansea, GB

28


PS4

K. Matsuda Yamanashi, JPJ. Hartmann Krems, AT

Dialysis/Apheresis - Experimental Approaches

Chairs :

Mathematic model of blood glucose dynamics

P

K. Pozhar; Moscow, Zelenograd, RU

29

Study of the effect of module geometry on forward filtration in hollow fiber dialyzers with a two-dimensional momentum transport model

P

D. Donato; Hechingen, DE

30

Modeling water transport across the cell membrane in HD patients

P

M. Pietribiasi; Warsaw, PL

31

Modified p(HEMA) cryogels as potential cell carriers for liver tissue engineering

P

F. Bonalumi; Brighton, GB

32

Sieving coefficients of hemodialysis membranes

P

M. Hulko; Hechingen, DE

33

Possible influence of hemodialysis on oxidative stress

P

P. Dejanov; Skopje, MK

34

Treatment of thrombotic microangiopathy with therapeutic plasma exchange using citrate anticoagulation

P

B. Bizjak; Ljubljana, SI

35

Citrate anticoagulation: Influence of haematocrit on the extraction ratio of citrate and urea

P

K. Strobl; Kems, AT

36

Influence of different anticoagulants on endotoxin activity in human serum

P

S. Harm; Krems, AT

37

Lipoprotein-associated phospholipase A2 Predicts Cardiovascular outcomes in peritoneal dialysis patients

P

M. Li; Hangzhou, CN

38

Challenge to a portable hemofiltration system in goat

P

H. Sugawara; Chuoshi, JP

39

Modeling of biotechnical system of artificial blood purification with wearable artificial kidney

P

N. Zhilo; Moscow, Zelenograd, RU

40

Trials of wearable artificial kidney SDR-01

P

N. Bazaev; Moscow, Zelenograd, RU

41

Risk Factors and Outcomes of Early Peritonitis in Chinese Peritoneal Dialysis Patients

P

Y. Tian; Hangzhou, CN

42

Long-term outcome of patients with rapidly progressive glomerulonephritis requiring dialysis treated with plasmapheresis: a retrospective, single-centre study

P

S. Kaixiang; Hangzhou, CN

43


PS5

K. Schneider Vienna, ATA. Repanas Halle, DE

Biomaterials - Hydrogels - Scaffolds I

Chairs :

Modification and optimization of polysaccharides for hydrogel formation

P

A. Repanas; Halle (Saale), DE

44

Pegylated hydrogels as a novel drug delivery system against prostate cancer

P


45

Reversible Gelatin Hydrogels based on Semi-Covalent Interactions

P

M. Vahedi; Tehran, IR

46

Mechanical and in-vitro performance of porous hydroxyapatite/poly(lactic acid)/polycaprolactone composite scaffolds

P

H. Ivanković; Zagreb, HR

47

Oxygen permeability measurement of contact lenses: critical points

P

G. D'Avenio; Rome, IT

48

Vibrational spectroscopy of albumin and collagen as materials for creation of biostructures

P

A. Polokhin; Moscow, Zelenograd, RU

49

The Study of Zeta Potential of Gold Nanorods Based on the Electrophoretic Light Scattering Method

P

S. Dolgushin; Zelenograd, Moscow, RU

50

Investigation of the long-term visco-elastic mechanical properties of hernia meshes

P

M. Doneva; Sofia, BG

51

Two scientist, three results - What is the challenge in measuring Magnesium degradation?

P

S. Knigge; Hannover, DE

52

Haemocompatibility assessment of a-C:N:H nitrogen modified, amorphous hydrogenated carbon surface layers on polyether ether ketone

P

M. Gonsior; Zabrze, PL

53

Preparation of atorvastatin calcium loaded PLGA microspheres using solid-in-oil-in-water emulsion method

P

R. Badiani; Tehran, IR

54

Sustained drug delivery of Cyclosporine A (CyA) for extended treatment of dry eye syndrome

P

F. Rafiei; tehran, IR

55

Influence of the degradation process on the release profile of idarubicin for the treatment of glioblastoma multiforme

P

A. Borecka; Sosnowiec, PL

56


PS6

S. Bahrami (tbc) Vienna, ATM. Müller Hannover, DE

Biomaterials - Hydrogels - Scaffolds II

Chairs :

A conceptual knowledge-based approach to support dental implants planning

P

A. Szejka; Curitiba, BR

57

Requirements to elaborate new design of devices and accessories of ostomy pouching system

P


58

Development for the driving mechanism of implantable artificial tongue

P

T. Yambe; Sendai, JP

59

Magnetically-controlled artificial urinary sphincters.

P

T. Mazzocchi; Pontedera (PI), IT

60

Research of inductive powering unit operation modes

P

E. Mindubaev; Moscow, RU

61

Laser fabrication of nanocarbone scaffolds in protein matrix for reconstruction cartilage and bone tissue

P

A. Gerasimenko; Moscow, RU

62

A new strontium and zinc doped bioglasses for tissue engineering

P

B. Zagrajczuk; Krakow, PL

63

Increasing of mechanical properties of artificial joint ligament by the bionanomaterials laser application method

P

L. Ichkitidze; Moscow, Zelenograd, RU

64

Small, smaller, smallest - A method to produce very small polymeric beads

P

S. Knigge; Hannover, DE

65

Numerical analysis of the PMMA-based cement flow in a trabecular structure of a vertebral

P

K. Sobczak; Lodz, PL

66

Electroactive poly(vinylidene fluoride) membranes with hydrophilic domains for osteogenic differentiation.

P

G. Gallego-Ferrer; Valencia, ES

67

Conducting Biocompatible Nanomaterial Layers

P


68


PS7

H. Lanmüller Vienna, AT

Varia

Chairs :

Superconducting Film Concentrator in Ultraweak Magnetic Field Sensors

P

L. Ichkitidze; Moscow, RU

69

Capacitive-Coupling-based Information Transmission System for Implantable Esophageal pH Monitoring Sensor and Stimulator: Analysis of Receiving Voltage for Electrode Position Modification in Human Anatomical Model

P

Y. Ishioka; Katsushika, JP

70

Possibilities of using combined magnetic field sensors in magnetocardiography

P


71

Flexible and Implantable Encapsulated Electrode for Measurement of Electrocardiogram

P

K. Lee; Chuncheon, KR

72

In memoriam Alex Medvedev, a career devoted to cardiac assist devices

P

I. Medvedev; Ann Arbor, US

143


PS8

A. Kocher Vienna, ATY. Takewa Osaka, JP

Valves

Chairs :

Methods of tilting disc valves evaluationP

P. Pydziński; Zabrze, PL

73

Polyurethane flexible valve for pulsatile ventricular assist devices

P

M. Gonsior; Zabrze, PL

74

In vitro evaluation of a Styrene-based Polymeric Transcatheter Aortic Valve: The Effect of Leaflet Thickness on Hydrodynamic Function

P

P. De Sciscio; Cambridge, GB

75

In Vitro Modelling of Calcific Particles under Physiological Conditions: A Testbed for Cerebral Protection Devices (CPDs)

P

C. Lierath; Aachen, DE

76

Influence of the bulging sinus size and shape of the stimulated livesize EPTFE valve on the leaflet movement of the valve conduit

P

T. Akutsu; Yokohama, JP

77


PS-L

T. Verbelen Leuven, BEU. Losert Vienna, AT

Late Abstract Poster Session I

Chairs :

Investigation of the axial gap clearance in a hydrodynamic-passive magnetically levitated rotary blood pump using X-ray radiography

PL

B. Thamsen; Zurich, CH

1

CFD study of a pulsatile ventricular assist device operating at high frequency

PL

C. Loosli; Zürich, CH

2

Performance and Efficiency of an Undulating Membrane Based Cardiac Assist Device

PL

P. Monticone; Paris, FR

3

Static and dynamic characterization of four rotary blood pumps

PL

S. Boës; Zurich, CH

4

The Effect of Pulsatility on Haemocompatibility Biomarkers of Rotary Blood Pumps

PL

J. Horobin; Gold Coast, AU

5

Application of soft robotics principles: a soft total artificial heart

PL

N. Cohrs; Zürich, CH

6

Requirements for outpatient care after implantation of a ventricular assist device – view of patients and their relatives

PL

T. Berg; Aachen, DE

7

“I can only sleep with the lights on now” – The different shades of psychologicalstress after critical illness

PL

A. Chan-Dominy; London, GB

8

07.09.2017,Thursday 16:30 18:00 2Hall:-

A14

A. Khir London, UKA. Molteni Swansea, GB

Experimental Models for Cardiovascular Devices

Chairs :

16:30 Mock Circulation for Ventricular Assist Devices

O

K. Affeld; Berlin, DE

44

16:45 In vitro flow investigation in the aorta with two different compliances using stereo PIV

O

I. Mueller; Aachen, DE

45

17:00 Optimisation of Numerical Haemolysis Model to Enable Accurate Prediction of Haemolysis Performance in Ventricular Assist Devices

O

A. Molteni; Swansea, GB

46

17:15 The Anastomosis Angle of Outflow Graft to Aorta Influences on Hemodynamics of Aortic Valve Regurgitation in Left Ventricular Assist Device Support

O

K. Iizuka; Osaka, JP

47

17:30 Cardiac Flow Patterns during Mechanical Circulatory Support as a possible Link to Stroke Development

O

P. Aigner; Vienna, AT

48

17:45 Nitric oxide administration to the gas inflow of oxygenator improves cerebral perfusion and neuroprotection during ECMO.

O

N. Ahmed; Verona, IT

49

07.09.2017,Thursday 16:30 18:00 4Hall:-

B14

R. Oberbauer Vienna, ATS. Eloot Ghent, BE

Challenges for Dialysis Devices

Chairs :

16:30 Haemodialyser clotting: the inner counts.

O

F. Vanommeslaeghe; Ghent, BE

50

16:42 Impact of Initial Dialysis Modality on the Survival of Patients with ESRD: a Propensity-Matched Study

O

X. Yao; Hangzhou, CN

51

16:54 Mass-spectrometry based plasma proteomics to find the underlying molecular determinants of hypertension

O

P. Gajjala; Aachen, DE

52

17:06 Blood foam in the air trap during haemodialysis

O


53

17:18 Differentiation and heterogeneity of biomaterial-induced multinucleated giant cells: connection between inflammation and tissue regeneration

O

M. Barbeck; berlin, DE

54

17:30 Cytokine Profiles In Sepsis PatientsO

T. Eichhorn; Krems, AT

55

17:42 The risk of catheter-related bloodstream infection with temporary femoral hemodialysis catheters

O

V. Gerasimovska; Skopje, MK

56

07.09.2017,Thursday 16:30 18:00 3Hall:-

C14

B. Walpoth Geneva, CHG. Faggian Verona, IT

Symposium: Challenges in Vascular Tissue Engineering

Chairs :

16:30 Vascular Tissue Engineering: "Quo Vadis?"

B. Walpoth; Geneva, CH

16:35 Cell-Assembled Extracellular Matrix (CAM) for Vascular Applications

IL

N. L'Heureux; Bordeaux, FR

16:55 Decellularized human umbilical artery as a potential scaffold for long small diameter tissue engineered vascular grafts

IL

A. Mishanin; St. Petersubrg, RU

17:10 S-Nitroso Human Serum Albumin Releasing Poly(ε-Caprolactone) Small Diameter Vascular Graft

O

M. Enayati; Vienna, AT

57

17:20 Neointima inducing process on small-diameter decellularized vascular graft modified with the bioactive peptide

O

A. Mahara; Osaka, JP

58

17:30 Decellularized small diameter vascular grafts from the human placenta: Assessment of the functional performance in a rat model

O

K. Schneider; Vienna, AT

59

17:40 Application of the xenogeneic decellularized tube matrix produced by in vivo tissue engineering to the 'off-the-shelf' small-caliber vascular graft

O

M. Yamanami; Kyoto, JP

60

17:50 Discussion

07.09.2017,Thursday 16:30 18:00 9Hall:-

D14

A. Remuzzi Bergamo, ITA. Dimasi (tbc) Milano, IT

Symposium: Numerical Modeling in Hemodialysis

Chairs :

16:30 Effect of double-filtration plasmapheresis for antibody-mediated rejection regarding coagulation parameters and thrombin generation

O

L. Rostaing; Grenoble, FR

124

16:45 Towards longitudinal analysis of arteriovenous fistula for hemodialysis using contrast-free magnetic resonance angiography

O

M. Bozzetto; Ranica (BG), IT

61

16:55 An experimental setup to study the occurrence of perivascular vibrations in arteriovenous vascular access

O

U. Krueger; Berlin, DE

62

17:05 Numerical hemodynamic simulations for monitoring of vascular patients

O

J. Carroll; Sydney, AU

63

17:15 Modelling of cardiovascular alterations during CKD progression

O

G. Casagrande; Milan, IT

64

17:25 Bayesian Identification of Patient-Specific Parameters in a Dialysis Kinetic Model

O

C. Bianchi; Milano, IT

65

17:35 Cardiovascular response to haemodialysis – a new integrated mathematical model

O

L. Pstras; Warsaw, PL

66

17:45 Vascular access in hemodialysis patients: from numerical modeling to vascular biology

IL

A. Remuzzi; Bergamo, IT

08.09.2017,Friday 08:30 09:30 2Hall:-

A21

A. Zuckermann (tbc Vienna, ATS. Jacobs Leuven, BE

Heart Regeneration and Transplantation

Chairs :

08:30 Characterization of miRNA expression in cardiac isograft vasculopathy using a heterotopic abdominal mouse heart transplantation model

O

A. Schaefer; Vienna, AT

67

08:42 Remote ischemic postconditioning improves post-ischemic cardiac function:the role of Neuregulin-1

O

P. Pilz; Vienna, AT

68

08:54 A morpho-biomechanical perspective on heart remodeling after MI

O

M. Rusu; Aachen, DE

69

09:06 The OCS HEART system for ex vivo perfusion of the donor heart: A step toward future?

O

l. Botta; Milano, IT

70

09:18 Comparing different unloading strategies in an ovine model of post-infarction heart failure.

O

S. Jacobs; Leuven, BE

71

08.09.2017,Friday 08:30 09:30 4Hall:-

B21

B. Stegmayr Umea, SEC. Tripisciano Krems, AT

Symposium: Extracellular Vesicles

Chairs :

08:30 Blood purification may interfere with microvesicles in blood

IL


08:40 Characterization of Extracellular Vesicles in Whole Blood: Influence of Preanalytical Parameters

O

B. Fendl; Krems, AT

72

08:50 Extracellular Vesicles- from Discovery to Clinical Application

IL

A. Reiner; Vienna, AT

09:10 Role of Phosphatidylserine and Tissue Factor in Supporting Extracellular Vesicles Induced Thrombin Generation

IL

C. Tripisciano; Krems, AT

09:20 Discussion

08.09.2017,Friday 08:30 09:30 3Hall:-

C21

B. Glasmacher Hannover, DED. Mavrilas Patras, Greece

Biomaterials II: Soft Tissue Replacement

Chairs :

08:30 The investigation of the influence of the laser solder composition on the welds tensile strength

O

D. Ryabkin; Zelenograd, RU

73

08:40 Investigation of bendability and anisotropy of fiber-based vascular grafts under physiological conditions

O

M. Bode; Hanover, DE

74

08:50 The anticalcification potential of Heparin on hydroxyapatite seed crystals

O

A. Badria; Rion-Patras, GR

75

09:00 The application of poly(L-lactide-co-glycolide-co-trimethylene carbonate) to formulate rods with 17-β-estradiol

O

A. Turek; Sosnowiec, PL

76

09:10 Enhanced Interfacial Bonding Strength of Hydrophobically-modified, Alaska pollock Gelatin-based Surgical Sealants

O

T. Taguchi; Tsukuba, JP

77

09:20 Long-term urine-resistant artificial bladder

O

T. Mazzocchi; Pontedera (PI), IT

78

08.09.2017,Friday 08:30 09:30 9Hall:-

D21

K. Affeld Berlin, DEM. Trivella Pisa, IT

Blood Trauma

Chairs :

08:30 Assessment of leukocyte functionality in contact with a foreign surface under shear stress

O

G. Radley; Swansea, GB

79

08:42 Shear stress exposure alters the electrochemical and physical properties of erythrocytes

O

A. McNamee; Gold Coast, AU

80

08:54 Numerical Comparison of Shear and Elongational Stresses in Rotary Ventricular Assist Devices

O

D. Khoo; Bath, GB

81

09:06 Ovine activated leukocyte microparticles generated by the CentriMag ventricular assist device in vitro

O

I. Pieper; Swansea, GB

82

09:18 Evaluation of hemocompatibility of a hydrodynamically levitated centrifugal blood pump using hyperspectral imaging in acute animal studies

O

R. Kosaka; Tsukuba, JP

83

08.09.2017,Friday 09:30 10:00 1Hall:-

PL II

K. Dasse Louisville, US

Plenary Session II

Chairs :

09:30 The Bionic Hand: Coupling the Brain to Prostheses

PL

O. Aszmann; Vienna, AT

3

10:00 Mechanical Cardiac Support and Cardiac Rhythm Management: A Marriage of two Technologies

PL

M. Hess; Minneapolis, US

4

08.09.2017,Friday 11:00 12:30 2Hall:-

A22

F. Consolo Milan, ITL. Wiegmann Zürich, CH

Symposium: Numerical Modelling: Design, Optimization and Functional Characterization of VAD's

Chairs :

11:00 Past and Future of Blood Damage Modelling in Biofluid Mechanics Laboratory

O

L. Goubergrits; Berlin, DE

84

11:12 Strain-Based Blood Damage Modeling – Current Status and Future Perspectives

O

L. Pauli; Aachen, DE

85

11:24 Computational fluid dynamic analyses and in vitro assessment of a novel microfluidic flow-based assay

O

A. Dimasi; Milano, IT

86

11:36 Numerical modeling of the thrombogenic potential of altered hemodynamics at the left ventricular apex-LVAD interface based on non-invasive patient-specific imaging techniques

O

F. Consolo; Milano, IT

87

11:48 Numerical design improvement and experimental testing of a small VAD

O

K. Fraser; Bath, GB

88

12:00 Influence of pump design variations on hydraulic performance and blood damage: a computational fluid dynamics analysis

O

L. Wiegmann; Zurich, CH

89

12:12 Robust computational tools to improve the development process of mechanical circulatory support

O

T. Kaufmann; Aachen, DE

90

12:24 Summary

08.09.2017,Friday 11:00 12:30 4Hall:-

B22

K. Derfler Vienna, ATY. Wu Seattle, US

Emerging Applications in Extracorporeal Therapies

Chairs :

11:00 Lp(a), a risk factor for cardiovascular disease a successful treatment with LDL apheresis

IL

K. Derfler; Vienna, AT

11:30 Extracorporeal therapies in the stem cell transplantation setting

IL

V. Witt; Vienna, AT

11:50 Selective apheresis of C-reactive protein: a new treatment option for myocardial infarction, stroke, pancreatitis, Crohn's disease, after bypass surgery and rheumatic diseases

IL

A. Sheriff; Berlin, DE

12:10 CytoSorb in liver failureIL

B. Tyczynski; Essen, DE

08.09.2017,Friday 11:00 12:30 3Hall:-

C22

T. Groth Halle, GEG. Gallego-Ferrer Valencia, ES

Symposium: Nanomedicine

Chairs :

11:00 Two Decades of Commercializing Nanomedicine for Artificial Organs

IL

T. Webster; Boston, US

11:25 3D Printing of Advanced Photopolymers in Tissue Engineering

IL

S. Baudis; Vienna, AT

11:45 Immobilization strategies with glycosaminoglycans-polymeric drug conjugate on biomaterials for anti-inflammatory purposes

O

H. Al-Khoury; Halle (Saale), DE

91

12:00 Electrospinning of fibres for nanomedical applications

O


92

12:15 Vascular grafts with defined fiber orientations

O

C. Grasl; Vienna, AT

93

08.09.2017,Friday 11:00 12:30 9Hall:-

D22

H. Schima Vienna, ATY. Taenaka Osaka, JP

Symposium: Regulatory Affairs

Chairs :

11:00 The new EU Medical Device RegulationIL

J. Vienken; Usingen, DE

11:20 Impact of New European MEDICAL DEVICE REGULATION (MDR) on Artificial Organs Regulatory Approval

O

U. Wallstab; Overath, DE

94

11:32 Clinical evaluation of artificial organs regulated as medical device

O

U. Wallstab; Overath, DE

95

11:44 3D printed medical devices under the perspective of EU regulation

O


96

11:56 Current Status of the Redemption Price of the Medical Devices in Japanese Insurance System during 2015-2016

O

E. Akagawa; Suita, JP

97

12:08 Nanostructured medical devices: the need for a specific roadmap of the regulatory framework

O


98

12:20 Discussion

08.09.2017,Friday 12:30 13:30 1Hall:-

LS II

S. Ash Lafayette, US

Lunch with Plenary Lecture 5

Chairs :

12:30 Dialysis: From an Awkward, Complicated Method to a Mass Therapy and Beyond

PL

E. Leonard; New York, US

5

08.09.2017,Friday 13:30 15:30 2Hall:-

A23

U. Kertzscher Berlin, DEM. Kameneva Pittsburgh, USA

Symposium: Blood Damage in Rotary Assist Devices

Chairs :

13:30 Blood trauma in rotary blood pumps, an introduction

U. Kertzscher; Berlin, DE

13:35 Advanced Surface Properties to Mitigate Hemolysis and Thrombosis

IL

M. Kameneva; Pittsburgh, US

13:50 Visualized erythrocyte’s shear induced damage process under high shear flow

O

N. Watanabe; Saitama-City, JP

99

14:02 Red blood cell responses to shear stress exposure in patients un/likely to receive mechanical circulatory support

O

M. Simmonds; Gold Coast, AU

100

14:14 Investigation of Shear-Induced Platelet Damage with a Couette Shear Device

O

M. Lommel; Berlin, DE

101

14:26 Von Willebrand Factor and a Correlation to Turbulence

O

K. Affeld; Berlin, DE

102

14:38 Can we predict the thrombotic risk in patients with Left Ventricular Assist Devices?

O

F. Consolo; Milano, IT

103

14:50 Influence of dynamically changing operating conditions on the hemocompatibilty of rotary blood pumps

O

B. Thamsen; Zurich, CH

104

15:02 A modified Chandler-Loop as a benchmark for hemodynamic simulation studies.

O

S. Engel; Hannover, DE

105

15:14 Panel Discussion

08.09.2017,Friday 13:30 15:30 4Hall:-

B23

B. Stegmayr Umea, SEB. Lindholm Stockholm, SE

Symposium: Dialysis of Today and Tomorrow

Chairs :

13:30 Introduction: Different survival on dialysis in USA, Europe and Japan


13:35 Japanese strategies of dialysis today and tomorrow

IL

K. Matsuda; Tokyo, JP

14:00 Carbon Block Column (CB) for Regeneration of Dialysate in CVVHD

O

S. Ash; Lafayette, Indiana, US

106

14:25 Large uremic toxins: clinical relevance and strategies for remova

IL

S. Eloot; Ghent, BE

14:37 Release of uremic retention solutes from protein binding by hypertonic predilution hemodiafiltration

IL

J. Jankowski; Aachen, DE

14:49 (Bio)artificial kidney systems for improved blood purification

IL

D. Stamatialis; Twente, NL

15:01 Peritoneal dialysis for urgent dialysis initiation

IL

B. Lindholm; Stockholm, SE

15:13 Discussion

08.09.2017,Friday 13:30 15:00 3Hall:-

C23

C. Radtke (tbc) Vienna, ATH. Redl Vienna, AT

Tissue Engineering & Regenerative Medicine II

Chairs :

13:30 TERM in the Austrian Cluster for Tissue Regeneration

IL

H. Redl; Vienna, AT

14:00 An influence of the zinc oxide nanoparticles on properties of the endothelial cells cultured under physiological flow

O

A. Ciechanowska; Warsaw, PL

107

14:12 Material-driven assembly of fibronectin (nano)networks in 2D substrates and 3D scaffolds: effect of chemical crosslinking on fibronectin organization

O

R. Sabater i Serra; València, ES

108

14:24 Microspheroid Assemblies : Levitating PCL –IO Spheroids in Biomaterial Applications – Insights from Respirometry

O

F. Fernandez; Trivandrum, IN

109

14:36 Human induced pluripotent stem cells-based strategies for bone tissue engineering and regeneration.

O

D. Marolt Presen; Vienna, AT

110

14:48 Osteogenic differentiation of human mesenchymal stem cells under physiological fluid shear stress

O

C. Kasper; Vienna, AT

111

08.09.2017,Friday 13:30 15:30 9Hall:-

D23

D. Mottaghy Aachen, DER. Ullrich Vienna, AT

Symposium: Artificial Lung

Chairs :

13:30 Extracorporeal support for the lungs: from research to clinics – from rescue to ethics

IL

M. Quintel; Göttingen, DE

14:00 Intracorporeal Membrane Catheter for CO2 Reduction in the Blood – Membrane Contactor

O

M. Harasek; Vienna, AT

112

14:15 In Vitro Characterization of the Pittsburgh Pediatric Ambulatory Lung Device

O

R. Orizondo; Pittsburgh, US

113

14:30 RAS-Q – A Novel Passive Right Heart Assist System

O

T. Kaufmann; Aachen, DE

114

14:45 Controlled Blood Recirculation Enhances Oxygenation Efficiency in an Artificial Lung

O

S. P. Madhani; Pittsburgh, US

115

15:00 Investigations of Thrombus Distribution After Long Term ECMO and Blood Flow Distribution Using CFD in An Oxygenator

O

N. KATAGIRI; Suita, Osaka, JP

116

15:15 In-Vitro and In-Vivo Studies of an Integrated, Wearable Blood Pump-Lung

O

S. Madhani; Pittsburgh, US

117

08.09.2017,Friday 15:30 16:30 HallwayHall:-

PS9

A. Andrade Sao Paulo, BRM. Granegger Zurich, CH

Pump Development

Chairs :

Long-term use Assessment of the Apico-Aortic Blood Pump: Durability and wear assessment

P

B. Utiyama; Sao Paulo, BR

78

Transventricular Assist Device (TVAD) – In Vitro evaluation of a new axial blood pump using polymeric valve for rotational speed reduction

P

A. Andrade; Sao Paulo, BR

79

Precision matching pulsatile blood pumpP

M. Yang; Shaghai, CN

80

Total artificial heart (TAH): preliminary results in vitro

P

D. Galantini; São Paulo, BR

81

Methodology for the Application of Risk Analysis to Improve the Reliability of Ventricular Assit Device

P

J. Dias; São Paulo, BR

82

Remote Monitoring of Russian VAD system AVK-N

P

G. Itkin; Moscow, RU

83

Tele-care and tele-rehabilitation model for VAD patient’s treatment

P

R. Kustosz; Zabrze, PL

84

Integration of Ultrasonic Flow Measurement in Cardiac Support Systems

P

E. Huber; Finning, DE

85

Design of a Smart System for a Ventricular Assist Device

P

M. Barboza; São Paulo, BR

86

Preliminary results of In Vitro endothelialization on plasma modified titanium surface

P

E. Drigo; São Paulo, BR

87

Design optimization and in vitro and in vivo verification of CorWave disk membrane LVAD

P

P. Monticone; Paris, FR

88


PS10

A. Di Molfetta Rome, ITF. Moscato Vienna, AT

Experimental and Numerical Modelling

Chairs :

In-vitro Measurement of Centering Forces on a Transvalvular Ventricular Assist Device Cannula

P

M. Stoiber; Vienna, AT

89

Blood viscosity investigation to define best numerical and in vitro test values to benchmark VAD performance

P

C. Moriarty; Swansea, GB

90

Quantitative assessment of heart-pump interaction for an axial-flow rotary blood pump Sputnik: in vitro study

P

D. Petukhov; Zelenograd, RU

91

Development of Frank-Starling mechanical mock circulatory loop for rotary blood pump testing

P

T. Khienwad; Nakhon Pathom, TH

92

Modelling the impact of hypertension on continuous flow left ventricular assist device function

P

C. Hayward; Sydney, AU

93

Computerized closed-loop propofol anaesthesia in cardiac surgery.

P

V. Magilevets; Moscow, RU

94

Virtual patient in studies of ventilation capacity improvement by LVAD support in congestive heart failure

P

K. Zielinski; Warsaw, PL

95

Fluid dynamical study of the univentricular patient: the case of HLHS

P

G. D'Avenio; Rome, IT

96

Minimal model of cardiovascular system assisted by a veno-arterial extracorporeal membrane oxygenation

P

S. Habran; Liege, BE

97

Evaluation of a hybrid cardiovascular simulator

P

J. Fonseca; Sao Paulo, BR

98

Measurements of pressure drop in arteriovenous fistula models - in vitro investigations

P

D. Jodko; Lodz, PL

99

Numerical Simulation of the HeartMate 3

P

M. Nicolai; Berlin, DE

100

Can Simulation Become a Preoperative Planning Approach in Patients Requiring Mechanical Circulatory Support?

P

M. Capoccia; Leicester, GB

101


PS11

M. Hiesmayr Vienna, ATS. Madhani Pittsburgh, US

Artificial Lung and Respiratory Support

Chairs :

Effects of Hollow Fiber Oscillation on Artificial Lungs

P

R. Orizondo; Pittsburgh, US

102

Multiobjective Design Optimization of Endothelializable Oxygenator Membranes Using Computational Fluid Dynamics

P

F. Hesselmann; Aachen, DE

103

Experimental Flow Visualization and Wall Shear Stress Measurements in an Endothelializable Membrane Oxygenator Using Particle Tracking Velocimetry

P

F. Hesselmann; Aachen, DE

104

Oxygen Mass Transfer in a Surrogate System of Membrane Blood Oxygenators

P

C. Moreira; Lisbon, PT

105

Intracorporeal Membrane Catheter for CO2 Reduction in the Blood – Drive Unit and Control System

P

M. Gföhler; Vienna, AT

106

The use of an artificial patient in analysis of possible causes of changes in arterial blood gases during therapeutic thoracentesis

P

A. Stecka; Warsaw, PL

107

In-vivo study of a novel lung support device for PAH and bridge-to-transplant/candidacy

P

T. Verbelen; Aachen, DE

108


PS12

G. Böhmig Vienna, ATV. Witt Vienna, AT

Dialysis/Apheresis - Clinical

Chairs :

Therapeutic apheresis in severe Guillain-Barre syndrome – our experience from 2009 to 2017

P

A. Marn Pernat; Ljubljana, SI

109

Immunology Absorption induces remission in ANCA-associated vasculitis

P

X. Lei; Hangzhou, CN

110

Changes of subjective global assessment is associated with clinical outcomes of peritoneal dialysis patients

P

X. Yan; Hangzhou, CN

111

Relationship between serum uric acid and all-cause mortality in maintenance hemodialysis patients

P

L. Zhang; Hangzhou, CN

112

Association between medical insurance type and survival in hemodialysis patients in China

P

X. Yao; Hangzhou, CN

113

Epidemiological Survey of Incident End Stage Renal Disease Patients from 2010 to 2014 in Zhejiang Province, China

P

W. Lei; Hangzhou, CN

114

Genome-wide analysis of DNA methylation and gene expression characteristics of dialysate-induced peritoneal fibrosis

P

P. Yan; Hangzhou, CN

115

Tamoxifen attenuates PDF-induced peritoneal fibrosis via reducing GSK3β/β-catenin axis activation

P

P. Yan; Hangzhou, CN

116


PS13

B. Kapeller Vienna, ATS. Baudis Vienna, AT

Tissue Engineering and Organ Regeneration I

Chairs :

An in vitro skin wound infection model and bioevaluation of antimicrobial wound dressings

P

A. Idrees; Bochum, DE

117

Development of Tissue-Engineered Cardiac Patch based on Silk Fibroin

P

Y. Nakazawa; Tokyo, JP

118

Microparticles from decellularized human liver tissue for increasing the biocompatibility of artificial grafts

P

M. Bobrova; Moscow, RU

119

Tissue engineering as a way for working out a bioartificial liver support at the treatment of chronic liver failure

P

M. Shagidulin; Moscow, RU

120

Preparation of Decellularized Porcine Renal Scaffolds for Potential Xenotransplantation: Technique and Biocompatibility Evaluation

P


121

Extract of cryopreserved piglets heart fragments as regulating agent proceeding of experimental myocardial necrosis

P

L. Rohoza; Kharkiv, UA

122

Characterization of the functionalized biodegradable collagen scaffolds for in vivo delivery of SDF-1α and substances with bactericidal activity

P

I. Pokholenko; Kyiv, UA

123

Genetically modified human hepatoma and feeder layer cells for bioartificial liver devices

P

A. Samluk; Warsaw, PL

124


PS14

M. Zenobi-Wong Zuerich, CHS. Nürnberger (tbc) Vienna, AT

Tissue Engineering and Organ Regeneration II

Chairs :

Development of an in-situ transfection system for regeneration of bone

P

Y. Brito Barrera; Halle (Saale), DE

125

Studies on osteogenic differentiation of cells on multilayers loaded with BMP-2

P

R. Anouz; Halle (Saale), DE

126

Effect of pO2 on viability and staging of bovine follicles cultured in vitro in dishes in strips of ovarian cortical tissue

P

G. Catapano; Rende, IT

127

Mathematical modeling and experimental procedures for tissue engineering of blood vessels by electrospinning

P

N. Filipovic; Kragujevac, RS

128

A Datamining Approach for Anatomic Skull Prosthesis Modelling Optimization

P


129

Effect of non-uniform construct permeability on matter distribution in radial flow packed bed bioreactors (rPBBs) for bone tissue engineering (BTE)

P

G. Falvo D'Urso Labate; Rende, IT

130

Non-contact Measurement of Dielectric Properties of Biological Tissues using Magnetic Induction at 500 kHz

P

S. Kawai; katsushika, JP

131

Controlled infiltration of cells into electrospun scaffolds fabricated for application in small diameter vascular grafts

P

S. Suresh; Hannover, DE

132


PS15

T. Hausner (tbc) Vienna, ATY. Takewa (tbc) Osaka, JP

Tissue Engineering and Regenerative Medicine

Chairs :

Poly(L-lactic acid) microspheres induce “in vivo” articular cartilage regeneration in rabbits

P

M. Sancho-Tello; Valencia, ES

133

Silk fibroin/collagen films for rat skin wound regeneration

P

L. Safonova; Moscow, RU

134

3D porous polycaprolactone scaffolds for cartilage regeneration

P

M. Sancho-Tello Valls; Valencia, ES

135

Force induced piezoelectric effect of PVDF and PVDF-TrFE scaffolds

P

F. AL Halabi; Hannover, DE

136

Poly(L-lactic acid) (PLLA) mats for human airway mucosa regeneration

P

M. Sancho-Tello Valls; Valencia, ES

137

Does excess gravity affect cell deformation and orientation after stimulation?

P

S. Hashimoto; Tokyo, JP

138

Measurement of Contraction of Myotube on Scaffold Film with Micro-markers by Electric Stimulation

P


139

Effect of the co-application of Matriderm and mesenchymal stem cells on wound healing

P

I. Lang; Graz, AT

140

Spheroid-based 3D culture model with PC12 cells for application of neuronal stimulation electrodes

P

S. Lee; Cheonju-si, Chungbuk, KR

141

Myoblast migrates under controlled wall shear stress field in vitro

P


142


PS-L

R. Ponikvar Ljubljana, SIA. Sikole (tbc) Skopje, MK

Late Abstract Poster Session II

Chairs :

In Vitro Testing of an Integrated, Low Flow Extracorporeal CO2 Removal Device

PL

A. May; Pittsburgh, US

9

Application of oxygen micro/nano bubble dispersions for total liquid ventilation

PL

H. Sato; Shinjuku, JP

10

A capillary membrane oxygenator with integrated pump function for organ transplant perfusion.

PL


11

Removal capability of CytoSorb hemadsorption columns for selected drugs frequently used for deliberate drug overdose

PL

A. Koertge; Rostock, DE

12

In Vitro Investigations of Membrane Permeabilities of Various Hemofilters

PL

T. Wild; Rostock, DE

13

A single venesection improves the mechanical properties of blood in patients with haemochromatosis

PL

K. Richardson; Gold Coast, AU

14

Effect of venous stenosis on flow resistance: A fluid dynamic model

PL


15

Tissue-engineered skeletal muscle and its application to actuator with long-term drivability

PL

T. Fujisato; Osaka, JP

16

08.09.2017,Friday 16:30 18:00 2Hall:-

A24

T. Kaufmann (tbc) Aachen, DES. Hashimoto Tokyo, JP

Computational Fluid Dynamics I

Chairs :

16:30 Evaluation of Numerical Models in Simulation of Intraventricular Flow Pattern with Left Ventricular Assist Device Support

O

M. Ghodrati; Vienna, AT

118

16:45 The effect of inflow cannula insertion lengths on the risk of ventricular thrombosis in a multiscale numerical model

O

S. Liao; Chermside, AU

119

17:00 Comparison of an Unsteady-Reynolds-Averaged and a Very-Large-Eddy Simulation regarding their Potential to Predict Hemolysis with Stress-Based Hemolysis Models

O

L. Konnigk; Rostock, DE

120

17:15 Numerical modelling of leukocyte deformation in Ventricular Assist Devices

O

K. Fraser; Bath, GB

121

17:30 An extensive comparison of power-law-based hemolysis models for the blood pump of the FDA’s Critical path challenge.

O

S. Engel; Magdeburg, DE

122

17:45 Development of Prediction Methods of Shear induced Thrombus Formation by CFD Method including Concentration Transport and Aggregation Process and by Thrombus Visualization Method

O

M. Tamagawa; Kitakyushu, JP

123

08.09.2017,Friday 16:30 18:00 4Hall:-

B24

J. Winters Rochester, USC. Aufricht Vienna, AT

Transplantation Related Aspects of Dialysis

Chairs :

16:30 Apheresis in Renal TransplantationIL

G. Böhmig; Vienna, AT

16:55 tba

17:10 Efficacy and Safety of Cinacalcet Therapy for Renal Transplant Patients with Secondary Hyperparathyroidism—A Systematic Review and Meta-Analysis

O

Y. Lu; Hangzhou, CN

125

17:25 Tacrolimus Dose Requirement Based on the CYP3A5 Genotype in Renal Transplant Patients

O

L. Qu; Hangzhou, CN

126

17:40 Discussion

08.09.2017,Friday 16:30 18:00 3Hall:-

C24

D. Stamatialis Twente, NLC. Legallais Compiegne, FR

"Bioartificial Organs" Working Group

Chairs :

16:30 Novel membrane systems for pancreatic cell encapsulation

IL

D. Stamatialis; Twente, NL

16:50 Advances in cell microencapsulation for bioartificial liver

IL

C. Legallais; Compiegne, FR

17:05 Can we bioengineer functional kidney tissue?

IL

R. Masereeuw; Utrecht, NL

17:20 Achievements and hurdles of kidney bioengineering

IL

A. Remuzzi; Bergamo, IT

17:35 Engineering blood and lymphatic vascular beds

IL

W. Holnthoner; Vienna, AT

17:50 Discussion

08.09.2017,Friday 16:30 18:00 9Hall:-

D24

G. Wieselthaler San Francisco, USG. Ferrari Pisa, IT

Clinical Reports and Exercise

Chairs :

16:30 Acute and Long-term effects of LVAD support on right ventricular function in children with pediatric pulsatile ventricular assist devices

O

R. Iacobelli; Rome, IT

127

16:45 Short and Long Term Changes in Ventricular Loading Condition in LVAD patients: pulsatile vs continuous flow LVAD

O

A. Di Molfetta; Rome, IT

128

17:00 Do LVADs provide sufficient cardiac support during physical exercise when driven at constant speed?

O

C. Gross; Vienna, AT

129

17:15 Exercise capacity in VAD and heart transplanted patients: a comparative study

O

L. Fresiello; Leuven, BE

130

17:30 The Clinical Results, Adverse Events, and Change of End-organ Function in Elderly Patients with HeartMateII LVAD ~Japanese Multicenter Study~

O

D. Yoshioka; Suita, JP

131

17:45 Viennese experience with the HeartMate III Left Ventricular Assist Device

O

K. Dimitrov; Vienna, AT

132

08.09.2017,Friday 18:00 19:00 12Hall:-

GA

T. Groth Halle, GES. Eloot Ghent, BE

ESAO General Assembly

Chairs :

18:00 only for members

09.09.2017,Saturday 08:30 09:30 2Hall:-

A31

L. Goubergrits Berlin, DEJ.R. Stanfield Salt Lake City, US

Computational Fluid Dynamics II

Chairs :

08:30 Fluid-Structure Interaction (FSI) Hemodynamic Optimization of CorWave Endovascular Cardiac Assist Device

O

F. Cornat; Paris, FR

133

08:40 Rotordynamic analysis of an artificial axial-flow cardiac-pump using Bond-graph methodology

O

J. Kumar; Rostock, DE

134

08:50 A novel generic model for the investigation of intraventricular flow patterns in individual hearts

O

K. Hugenroth; Aachen, DE

135

09:00 CFD modeling of IABP-induced abdominal occlusions and statistical analysis of effects on hemodynamics

O

G. Fragomeni; Catanzaro, IT

136

09:10 Effect of inflow cannulas side-hole number on drainage flow characteristics: flow dynamic analysis using numerical simulation

O

T. Goto; HIrosaki, JP

137

09:20 Modeling Maturation of Patient-Specific Arteriovenous Fistula's Using Computational Fluid Dynamics

O

E. Colley; Sydney, AU

138

09.09.2017,Saturday 08:30 09:30 4Hall:-

B31

J. Jankowski Aachen, DEG. Cohen Vienna, AT

Uremic Toxins I: EUTOX Symposium

Chairs :

08:30 Intra-dialyser Transmembrane and Hydrostatic pressures and convection: Measurement pitfalls and relevance

IL

À. Argilés; Montpellier, FR

08:50 Bubbling the extra-corporeal circuits: where the bubbles come from, are they harmful and can we prevent their appearance?

IL


09:10 Protein – bound toxins: Increased release results in increased removal

IL

J. Jankowski; Aachen, DE

09.09.2017,Saturday 08:30 09:30 3Hall:-

C31

C. Kasper Vienna, ATH. Bergmeister Vienna, AT

Tissue Engineering & Regenerative Medicine III

Chairs :

08:30 Fabrication of Proanthocyanidin cross-linked Chitosan-Gelatin hydrogel scaffolds for tissue engineering

O

A. Encerrado Flores; Nottingham, GB

139

08:42 Fabrication of porous poly(trimethylene carbonate) membranes for lungs-on-chips

O

T. Pasman; Enschede, NL

140

08:54 Rapamycin Inhibits Epithelial-to-Mesenchymal Transition of Peritoneal Mesothelium Cells through Regulation of RhoGTPases

O

X. Shilong; Hang Zhou,Zhe Jiang, CN

141

09:06 Decellularized Liver Extracellular Matrix Gel Promotes Resolution of Liver Fibrosis in Mice

O


142

09:18 Towards a fully implantable autonomous artificial pancreas

O

V. Iacovacci; Pontedera, IT

143

09.09.2017,Saturday 08:30 09:30 9Hall:-

D31

J. Jacak Linz, ATF. Moscato Vienna, AT

Symposium: 3D Additive Manufacturing / Biofabrication

Chairs :

08:30 Nanostructuring and nanoscopy in 3DIL

J. Jacak; Linz, AT

08:45 Application of indirect optical micromanipulation in fluorescent, 3D live cell imaging

IL

L. Kelemen; Szeged, HU

09:00 Generation of photo-induced microstructures on biomaterial surfaces for control of cell attachment.

IL

J. Heitz; Linz, AT

09:15 Open-source 3D biofabrication platform for specialized scientific and industrial solutions

IL

B. Vihar; Maribor, SI

09.09.2017,Saturday 09:30 10:30 1Hall:-

PL III

B. Meyns Leuven, BEJ. Jankowski Aachen, DE

Plenary Session III

Chairs :

Apheresis for Dilated CardiomyopathyPL

J. Winters; Rochester, US

6

09:30 Medical device innovation in Asia and Japan - Present and future strategy

PL

Y. Taenaka; Osaka, JP

7

09.09.2017,Saturday 11:00 12:30 2Hall:-

A32

C. Marko Vienna, ATT. Elliott Washington DC, US

Symposium: Challenges in Tailoring a Rehabilitation Program

Chairs :

11:00 How to set up a rehabilitation program for patients with left ventricular assist device

IL

N. Reiss (tbc); Bad Rothenfelde, DE

11:15 Can rehabilitation prevent LVAD related complications?

IL

C. Hayward; Sydney, AU

11:30 Hot topics in the long term psycho-social care

IL

C. Kugler; Freiburg, DE

11:45 Experiences of rehabilitation of LVAD patients in Austria

IL

12:00 Panel Discussion

09.09.2017,Saturday 11:00 12:30 4Hall:-

B32

À. Argilés Montpellier, FRZ. Chen (tbc) Hangzhou, CN

Uremic Toxins II

Chairs :

11:00 Exploring protein binding of different uraemic toxins

O

O. Deltombe; Ghent, BE

144

11:12 Modelling uremic toxicity: further steps towards a precise in vitro detection of toxic effects caused by uremic retention solutes

O

T. Vollmer; Berlin, DE

145

11:24 Not creatinine but protein-bound uraemic toxins are predominant in the prediction of QoL in children with CKD

O

E. Snauwaert; Ghent, BE

146

11:36 Alkaline phosphatase and combined alkaline phosphatase and iPTH influences clinical outcome in peritoneal dialysis patients

O

Z. Chen; Hangzhou, CN

147

11:48 Clinical investigation of 120 peritoneal dialysis patients combined with extraosseous calcification

O

S. Wang; Hangzhou, CN

148

12:00 Numerical modelling of microcirculation fluid exchanges in uremic patients accounting for the non-linear effect of lymphatic system

O

L. Possenti; Milan, IT

149

12:12 Which Uremic Toxins are Affecting Vascular Calcification?

O

J. Holmar; Aachen, DE

150

12:24 Discussion

09.09.2017,Saturday 11:00 12:30 3Hall:-

C32

G. Catapano Rende, ITA. Campbell Ritchie Nottingham, UK

Tissue Engineering & Regenerative Medicine IV

Chairs :

11:00 Strategies for the expansion and differentiation of human mesenchymal stem cells under physiological conditions

O

C. Kasper; Vienna, AT

151

11:20 3D oxygen transport model in strips of ovarian cortical tissue: a basic tool for assisted reproduction techniques

O

G. Falvo D'Urso Labate; Rende, IT

152

11:32 Fiber size and composition as tools to manipulate wettability and compliance of electrospun tubular scaffolds to enhance tissue regeneration.

O

M. Mueller; Hannover, DE

153

11:44 Laser engraving promotes the repopulation of decellularized articular cartilage

O

S. Nürnberger; Vienna, AT

154

11:56 Regeneration and Osteointegration of the Anterior Cruciate Ligament using a Novel Silk Fiber based Scaffold

O

T. Nau; Vienna, AT

155

12:08 Development of Injectable Cell Scaffold for Cell Therapy

O

T. Furuzono; Kinokawa, Wakayama, JP

156

12:20 Discussion

09.09.2017,Saturday 11:00 12:30 9Hall:-

D32

T. Masuzawa Hitachi, JPJ. Canizo Madrid, ES

Ventricular Assist Devices: The next Generation

Chairs :

11:00 Relationship between fluid force fluctuation and impeller design for magnetically levitated centrifugal blood pumps

O

T. Masuzawa; Hitachi, JP

157

11:15 Development of a hydrodynamically levitated centrifugal blood pump for long-term extracorporeal mechanical circulatory support systems

O

T. Tsukiya; Suita, JP

158

11:30 A Novel, Miniaturized VAD Configured for Right-Heart MCS

O

J. Stanfield; Salt Lake City, US

159

11:45 Novel Pediatric Axial Rotary Blood PumpO

D. Telyshev; Moscow, RU

160

12:00 Development of a Miniature, Hemocompatible Continuous Flow Pediatric Ventricular Assist Device

O

J. Stanfield; Salt Lake City, US

161

12:15 Next generation ultracompact centrifugal pediatric VAD with full axis controlled maglev motor

O

M. Osa; Hitachi, JP

162

09.09.2017,Saturday 12:30 13:00 1Hall:-

CC

T. Groth Halle, DEH. Schima Vienna, AT

Closing Ceremony

Chairs :

12:30 Closing Remarks: ESAO President

C. Legallais; Compiegne, FR

12:35 Closing Remarks: IFAO President


12:40 Presentation of the ESAO Innovation Award and the ESAO Poster Awards

12:50 Announcement of the next ESAO Congress

J. Canizo; Madrid, ES

12:55 Announcement of the next IFAO Congress

13:00 Farewell Lunch

http://esao.org/yesao

http://www.esao.org/yesao/events

WEDNESDAY, September 6th

ICCAC/ESAO MCS Proficiency Course

09:00-12:00 and 13:00-15:30, Level 08

Chairs:

Thomas Schlöglhofer, Medical University of Vienna, Austria

Dawn Christensen, Innovative Program Solutions LLC, Pine Grove, USA

Faculty:

Pamela Combs, Advocate Christ Medical Center, USA

Friedrich Kaufmann, German Heart Center, Berlin, Germany

Johann Horvat, Medical University of Vienna, Austria

Jodie Lantz, Children´s Health Dallas, USA

Heather Moody, University of Louisville, USA

Katrien Vandersmissen, UZ Leuven, Belgium

Tonya Elliott, MedStar Washington Hospital Center, USA

Gro Sørensen, Oslo University Hospital, Norway

Roman Kustosz, Clinic Zabrze, Poland

Harald Schwingenschlögl, Medical University of Vienna, Austria

Mark Puhlman, Providence St Vincent’s, Portland, USA

Daniela Roefe, Heart and Diabetes Center NRW, Bad Oeynhausen, Germany

Program Overview:

Time HVAD 1 HVAD 2 HM II HM 3 BerlinHeart OR

KR27 KR28 KR29 KR30 KR23 KR23

09:00 Introduction - Session Instructions (KR23)

09:15 S1 Session 1 S3 Session 1 S5 Session 1 S7 Session 1 S9 Session 1 S11 Session 1


09:45

10:00 Switch Rooms



10:45

11:00 Switch Rooms



11:45

12:00

Lunch Break 12:15

12:30

12:45



13:30

13:45 Switch Rooms



14:30

14:45 Switch Rooms



15:30

Course Description:

This course utilizes a small group construct in which participants proceeded through 6

separate stations over the 6 hour course. These stations consist of problem based learning

scenarios designed to reinforce critical thinking skills necessary to care for an advanced heart

failure patient who is supported by a MCS device.

Each station is 45min in length and will be repeated 6 times throughout the day (including 2

scenarios, each 20min)

6 stations will be in progress in each of the time slots throughout the day in 6 different rooms

allowing for a maximum of 60 participants.

Participants will be assigned to a group of no more than 10 individuals to encourage

participation by attendees. Group interaction and discussion is the basis for success in this

educational experience.

Scenarios will be run by International VAD Coordinator Faculty

Scenario Topics:

Room Faculty Names Scenario Topics*

HVAD 1 (KR27) G. Sørensen S1: Outflow graft thrombosis

F. Kaufmann S2: Comb. Inflow/Pump Thrombus

HVAD 2 (KR28) R. Kustosz S3: Waveform Interpretation

K. Vandersmissen S4: Driveline Infection

HM II (KR29) M. Puhlman S5: Controller Malfunction

T. Elliott S6: Aortic Insufficiency

HM 3 (KR30) D. Roefe S7: Major Bleeding (Tamponade)

H. Moody S8: Pump optimization

BerlinHeart (KR23) J. Lantz S9: Poor ejection

H. Schwingenschlögl S10: Poor filling

OR (KR23) J. Horvat S11: HVAD Wet Test

P. Combs S12: HM3 Wet Test

* Scenario topics are tentative and subject to change.

Documents

ESAO - IFAO Program, as of 03-08-2017 · 2017-08-04 · ESAO - IFAO Program, as of 03-08-2017 Tuesday, 05.09.201712:30- 18:00Hall: 7 PC1PreCongress Meeting: yESAO (I) 12:30 "The Grand